» Articles » PMID: 34224817

Protein S-nitrosylation and Oxidation Contribute to Protein Misfolding in Neurodegeneration

Overview
Date 2021 Jul 5
PMID 34224817
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative disorders like Alzheimer's disease and Parkinson's disease are characterized by progressive degeneration of synapses and neurons. Accumulation of misfolded/aggregated proteins represents a pathological hallmark of most neurodegenerative diseases, potentially contributing to synapse loss and neuronal damage. Emerging evidence suggests that misfolded proteins accumulate in the diseased brain at least in part as a consequence of excessively generated reactive oxygen species (ROS) and reactive nitrogen species (RNS). Mechanistically, not only disease-linked genetic mutations but also known risk factors for neurodegenerative diseases, such as aging and exposure to environmental toxins, can accelerate production of ROS/RNS, which contribute to protein misfolding - in many cases mimicking the effect of rare genetic mutations known to be linked to the disease. This review will focus on the role of RNS-dependent post-translational modifications, such as S-nitrosylation and tyrosine nitration, in protein misfolding and aggregation. Specifically, we will discuss molecular mechanisms whereby RNS disrupt the activity of the cellular protein quality control machinery, including molecular chaperones, autophagy/lysosomal pathways, and the ubiquitin-proteasome system (UPS). Because chronic accumulation of misfolded proteins can trigger mitochondrial dysfunction, synaptic damage, and neuronal demise, further characterization of RNS-mediated protein misfolding may establish these molecular events as therapeutic targets for intervention in neurodegenerative diseases.

Citing Articles

From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis.

Stanciu S, Jurcut R, Dragoi Galrinho R, Stefani C, Miricescu D, Rusu I Int J Mol Sci. 2025; 26(1.

PMID: 39796004 PMC: 11719977. DOI: 10.3390/ijms26010146.


Neuroinflammation in Alzheimer disease.

Heneka M, van der Flier W, Jessen F, Hoozemanns J, Thal D, Boche D Nat Rev Immunol. 2024; .

PMID: 39653749 DOI: 10.1038/s41577-024-01104-7.


Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias.

Oh C, Nakamura T, Zhang X, Lipton S Neuron. 2024; 112(23):3823-3850.

PMID: 39515322 PMC: 11624102. DOI: 10.1016/j.neuron.2024.10.013.


Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers.

Anjo S, He Z, Hussain Z, Farooq A, McIntyre A, Laughton C Antioxidants (Basel). 2024; 13(6).

PMID: 38929122 PMC: 11200609. DOI: 10.3390/antiox13060681.


Nitrooxidative Stress and Neuroinflammation Caused by Air Pollutants Are Associated with the Biological Markers of Neurodegenerative Diseases.

Ramirez-Mendoza A, Mendoza-Magana M, Ramirez-Herrera M, Hernandez-Nazara Z, Dominguez-Rosales J Antioxidants (Basel). 2024; 13(3).

PMID: 38539859 PMC: 10968023. DOI: 10.3390/antiox13030326.


References
1.
Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

2.
Salvador N, Aguado C, Horst M, Knecht E . Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state. J Biol Chem. 2000; 275(35):27447-56. DOI: 10.1074/jbc.M001394200. View

3.
Soto C . Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003; 4(1):49-60. DOI: 10.1038/nrn1007. View

4.
Reynaert N, Ckless K, Korn S, Vos N, Guala A, Wouters E . Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A. 2004; 101(24):8945-50. PMC: 428452. DOI: 10.1073/pnas.0400588101. View

5.
Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y . Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008; 64(1):60-70. PMC: 2674108. DOI: 10.1002/ana.21425. View